Amalgamated Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$495K Buy
15,717
+152
+1% +$4.79K ﹤0.01% 1287
2025
Q1
$510K Sell
15,565
-554
-3% -$18.2K ﹤0.01% 1246
2024
Q4
$583K Buy
16,119
+3
+0% +$109 ﹤0.01% 1249
2024
Q3
$502K Sell
16,116
-260
-2% -$8.1K ﹤0.01% 1298
2024
Q2
$438K Sell
16,376
-441
-3% -$11.8K ﹤0.01% 1350
2024
Q1
$574K Sell
16,817
-6,059
-26% -$207K ﹤0.01% 1260
2023
Q4
$662K Sell
22,876
-505
-2% -$14.6K 0.01% 1327
2023
Q3
$645K Sell
23,381
-673
-3% -$18.6K 0.01% 1295
2023
Q2
$723K Buy
24,054
+1,822
+8% +$54.8K 0.01% 1269
2023
Q1
$805K Sell
22,232
-1,821
-8% -$65.9K 0.01% 1196
2022
Q4
$858K Buy
24,053
+416
+2% +$14.8K 0.01% 1210
2022
Q3
$800K Buy
23,637
+188
+0.8% +$6.36K 0.01% 1198
2022
Q2
$678K Buy
23,449
+70
+0.3% +$2.02K 0.01% 1318
2022
Q1
$756K Sell
23,379
-1,167
-5% -$37.7K 0.01% 1348
2021
Q4
$716K Sell
24,546
-593
-2% -$17.3K 0.01% 1398
2021
Q3
$670K Sell
25,139
-475
-2% -$12.7K 0.01% 1441
2021
Q2
$789K Buy
+25,614
New +$789K 0.01% 1400
2020
Q1
Sell
-9,379
Closed -$222K 1769
2019
Q4
$222K Buy
9,379
+117
+1% +$2.77K ﹤0.01% 1589
2019
Q3
$255K Sell
9,262
-94
-1% -$2.59K 0.01% 1418
2019
Q2
$310K Buy
9,356
+1,458
+18% +$48.3K 0.01% 1333
2019
Q1
$277K Buy
7,898
+178
+2% +$6.24K 0.01% 1314
2018
Q4
$256K Buy
+7,720
New +$256K 0.01% 1269
2018
Q3
Sell
-8,007
Closed -$479K 1607
2018
Q2
$479K Buy
8,007
+1,028
+15% +$61.5K 0.01% 1050
2018
Q1
$320K Sell
6,979
-103
-1% -$4.72K 0.01% 1177
2017
Q4
$282K Buy
7,082
+543
+8% +$21.6K 0.01% 1302
2017
Q3
$262K Sell
6,539
-39
-0.6% -$1.56K 0.01% 1301
2017
Q2
$284K Buy
+6,578
New +$284K 0.01% 1227